Drug Trial Radar · NCT07573462
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,400
Planned (sponsor's estimate)
Start
May 4, 2026
Primary completion
Dec 30, 2028
Study completion Dec 30, 2028
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 42 days, up to 98 days
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumococcal vaccine that is currently in use, 20vPnC (Prevnar 20®). This study will test if the new pneumococcal vaccine is as safe as the one that is currently in use. This new vaccine can possibly provide additional protection against germs that cause pneumococcal disease that are not included in the vaccines that are currently given to infants. Pneumococcal disease includes a variety of infections caused by a specific germ, Streptococcus pneumoniae. There are two groups in this study. All participants will be assigned to one of the two groups. This study is seeking participants who are: \- infants who are about 2 months of age About 2400 infants will be assigned by chance to one of the two groups to receive either PG4 (new vaccine) or 20vPnC (currently in use) into the left thigh muscle at 2, 4, 6, and 12 to 15 months of age. Infants will take part in this study for about 16 to 19 months (about 1 and a half years). During this time, infants will have 6 study clinic visits and 1 phone call. At these study clinic visits, parent(s)/legal guardian(s) will be asked if the infant experienced any side effects. A side effect is an unintentional or unexpected reaction to a vaccine.
Conditions
- Pneumococcal Disease
Interventions
PG4Biological
Multivalent Pneumococcal Vaccine
20-valent pneumococcal conjugate vaccine (20vPnC)Biological
20-valent pneumococcal conjugate vaccine (20vPnC)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants reporting local reactions within 7 days after each doseTime frame: Day 7
- Percentage of participants reporting systemic events within 7 days after each doseTime frame: Day 7
- Percentage of participants reporting adverse events (AEs) from Dose 1 to 1 month after Dose 3Time frame: Dose 1 to 1 month after Dose 3
- Percentage of participants reporting AEs from Dose 4 to 1 month after Dose 4Time frame: Dose 4 to 1 month after Dose 4
- Percentage of participants reporting serious adverse events (SAEs)Time frame: Dose 1 to 6 months after Dose 4
Locations
91 sites in 11 countries. Site status is shown where the registry gives one.
Starz Pediatrics
Estero, Florida · Recruiting
Innovate Research Centers, LLC
Fort Lauderdale, Florida · Recruiting
MacKoul Pediatrics Fort Myers
Fort Myers, Florida · Recruiting
Speranza Research Center
Hialeah, Florida · Recruiting
Dr. Gala, LLC
Miami, Florida · Recruiting
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia · Recruiting
Rosemark Women Care Specialists
Idaho Falls, Idaho · Recruiting
Eagle Clinical Research
Chicago, Illinois · Recruiting
Kentucky Pediatric/ Adult Research
Bardstown, Kentucky · Recruiting
LSU Health Shreveport Clinical Trials Office
Shreveport, Louisiana · Recruiting
Ochsner LSU Health - Progressive Pediatrics
Shreveport, Louisiana · Recruiting
Ochsner LSU Health Shreveport Academic Medical Center
Shreveport, Louisiana · Recruiting
Ochsner LSU Health Shreveport Ambulatory Care Center
Shreveport, Louisiana · Recruiting
Pediatric Associates of Fall River
Fall River, Massachusetts · Recruiting
Lincoln Pediatric Group
Lincoln, Nebraska · Recruiting
Boston Children's Health Physicians
Hawthorne, New York · Recruiting
Maria Fareri Children's Hospital
Valhalla, New York · Recruiting
Senders Pediatrics
South Euclid, Ohio · Recruiting
Legacy Clinical Trials
Oklahoma City, Oklahoma · Recruiting
Cyn3rgy Research Corporation
Gresham, Oregon · Recruiting
Donald Guthrie Foundation
Sayre, Pennsylvania · Recruiting
Guthrie Medical Group
Sayre, Pennsylvania · Recruiting
Tribe Clinical Research LLC. at Parkside Pediatrics Five Forks
Simpsonville, South Carolina · Recruiting
Vast Clinical Research - Ivy Children's Clinic
Euless, Texas · Not yet recruiting
National Research Centers, Plano LLC
Plano, Texas · Recruiting
Pediatric Research of Charlottesville, LLC.
Gordonsville, Virginia · Recruiting
Instituto Médico Río Cuarto
Río Cuarto, Córdoba Province, Argentina · Not yet recruiting
Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L
San Miguel de Tucumán, Tucumán Province, Argentina · Not yet recruiting
Hospital del Niño Jesus
San Miguel de Tucumán, Tucumán Province, Argentina · Not yet recruiting
The Children's Hospital at Westmead
Westmead, New South Wales, Australia · Recruiting
Queensland Children's Hospital
Brisbane, Queensland, Australia · Recruiting
Centre for Children's Health Research
South Brisbane, Queensland, Australia · Recruiting
Monash Health
Clayton, Victoria, Australia · Recruiting
Murdoch Children's Research Institute
Parkville, Victoria, Australia · Recruiting
Perth Children's Hospital
Nedlands, Western Australia, Australia · Recruiting
The Kids Research Institute Australia
Nedlands, Western Australia, Australia · Recruiting
CHU de Quebec - Universite Laval
Québec, Canada · Not yet recruiting
Centre Hospitalier Universitaire Laval
Québec, Canada · Not yet recruiting
Milestone Research Inc.
London, Ontario, Canada · Recruiting
Bluewater Clinical Research Group Inc.
Sarnia, Ontario, Canada · Recruiting
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.